Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.

Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. Patients demonstrating a high baseline activation of interferon stimulated...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Scott A Read, Enoch S Tay, Mahsa Shahidi, Kate S O'Connor, David R Booth, Jacob George, Mark W Douglas
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2015-01-01
coleção:	PLoS ONE
Acesso em linha:	https://doi.org/10.1371/journal.pone.0136227
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!